Total Visits

Views
Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792)171

Total Visits Per Month

January 2024February 2024March 2024April 2024May 2024June 2024July 2024
Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792)130105144

Top country views

Views
Poland64
United States60
Cyprus10
India5
China4
Ireland4
Australia1
France1
Greece1
Macedonia1

Top cities views

Views
Warsaw64
Menlo Park12
Limassol10
Louisville10
San Ramon6
Villa Park5
Boardman4
Philadelphia4
Ashburn3
Dublin3